Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Medicilon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10565
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Medicilon Inc (Medicilon) is a drug discovery company that offers integrated services across biology, preclinical, chemistry, and drug discovery processes. The company provides chemistry services such as process development, medicinal chemistry, synthesis chemistry, and analytical chemistry. It offers drug formulation services such as pre-formulation development, research on quality control, analytical development, formulation development, and clinical trial material. Medicilon provides biology services such as crystallization and structural determination, recombinant protein services, discovery biology services, media sales, and computational biology and molecular modeling. The company also provides pharmacology, pharmacokinetic, contract research, bioanalytical and drug safety evaluation services. It caters to pharmaceutical and biotechnology companies. Medicilon is headquartered in Shanghai, China.

Shanghai Medicilon Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 10
SK Biopharma Enters Into Collaboration Agreement With PKU International HealthCare And Shanghai Medicilon 11
Wuxi Beita Enters Into Co-Development Agreement With Shanghai Medicilon For C14 Technologies 12
Shanghai Medicilon Inc – Key Competitors 13
Shanghai Medicilon Inc – Key Employees 14
Shanghai Medicilon Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Other Significant Developments 16
Nov 07, 2018: Shanghai Medicilon:Rare genetic disorder research opens door to novel melanoma therapy 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 10
SK Biopharma Enters Into Collaboration Agreement With PKU International HealthCare And Shanghai Medicilon 11
Wuxi Beita Enters Into Co-Development Agreement With Shanghai Medicilon For C14 Technologies 12
Shanghai Medicilon Inc, Key Competitors 13
Shanghai Medicilon Inc, Key Employees 14
Shanghai Medicilon Inc, Other Locations 15
Shanghai Medicilon Inc, Joint Venture 15

List of Figures
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Grid2020, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • HDFC Standard Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Newfield Exploration Company:戦略・SWOT・企業財務分析
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Litha Healthcare Group Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Inzpire Limited:企業の戦略・SWOT・財務情報
    Inzpire Limited - Strategy, SWOT and Corporate Finance Report Summary Inzpire Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Streck Inc:企業の製品パイプライン分析2018
    Summary Streck Inc (Streck) is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentation-rate, chemistry, whole blood, whole blood glucose and hemoglobin, instrum …
  • Inox Wind Ltd (INOXWIND):電力:M&Aディール及び事業提携情報
    Summary Inox Wind Ltd (IWL), a subsidiary of Gujarat Fluorochemicals Limited, is a provider of wind energy solutions to independent power producers (IPPs), PSUs, utilities, corporates and retail investors. The company manufactures and markets wind turbine generators; and offers turnkey solutions suc …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • Randstad Holding NV (RAND):企業の財務・戦略的SWOT分析
    Randstad Holding NV (RAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Verisante Technology Inc:企業の戦略的SWOT分析
    Verisante Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Linamar Corporation:企業の戦略・SWOT・財務分析
    Linamar Corporation - Strategy, SWOT and Corporate Finance Report Summary Linamar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Zenotech Laboratories Ltd (532039):企業の財務・戦略的SWOT分析
    Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • T-Mobile Netherlands Holding B.V.:企業の戦略的SWOT分析
    T-Mobile Netherlands Holding B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Den-Mat Holdings LLC-医療機器分野:企業M&A・提携分析
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that develops and manufactures dental products. The company provides products such as curing lights, finishing and polishing, impressions, instruments, lesion detection, magnification/illumination, oral hygiene, restoratives, soft ti …
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • Creganna Medical:医療機器:M&Aディール及び事業提携情報
    Summary Creganna Medical (Creganna), a subsidiary of TE Connectivity Ltd, formerly known as Creganna-Tactx Medical, is a provider of medical device outsourcing solutions. The company is. It undertakes the design, manufacturing and commercialization of minimally & less invasive delivery and access de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆